Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2023 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
3 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
MariMed Reports Fourth Quarter and Full Year 2023 Earnings
6 Mar 24
8-K
Entry into a Material Definitive Agreement
20 Nov 23
8-K
MariMed Reports Third Quarter 2023 Earnings
8 Nov 23
8-K
Departure of Directors or Certain Officers
3 Nov 23
8-K
MariMed Reports Second Quarter 2023 Earnings
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
8-K
MariMed Reports First Quarter 2023 Earnings
8 May 23
8-K
MariMed Expands Board With the Addition of Kathleen Tucker
17 Apr 23
8-K
Amendments to Articles of Incorporation or Bylaws
6 Mar 23
8-K
MariMed Reports Fourth Quarter
1 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
7 Mar 23
424B3
Prospectus supplement
28 Apr 21
S-3
Shelf registration
19 Apr 21
S-8
Registration of securities for employees
4 Feb 21
10-12G/A
Registration of securities (amended)
13 Feb 12
10-12G/A
Registration of securities (amended)
24 Jan 12
10-12G/A
Registration of securities (amended)
6 Dec 11
10-12G/A
Registration of securities (amended)
7 Oct 11
10-12G/A
Registration of securities (amended)
4 Aug 11
10-12G
Registration of securities
9 Jun 11
Other
EFFECT
Notice of effectiveness
29 Apr 21
CORRESP
Correspondence with SEC
27 Apr 21
UPLOAD
Letter from SEC
23 Apr 21
UPLOAD
Letter from SEC
7 Feb 20
CORRESP
Correspondence with SEC
21 Jan 20
CORRESP
Correspondence with SEC
6 Jan 20
UPLOAD
Letter from SEC
23 Dec 19
UPLOAD
Letter from SEC
24 Feb 12
CORRESP
Correspondence with SEC
13 Feb 12
UPLOAD
Letter from SEC
3 Feb 12